PharmaShots | Incisive News in 3 Shots

Subscribe Now

Brii Biosciences

Brii Biosciences Report Interim Results from P-II Study of BRII-179 (VBI-2601) + PEG-IFNα for the Treatment of Chronic Hepatitis B

Brii Biosciences Report Interim Results from P-II Study of BRII-179 (VBI-2601) + PEG-IFNα for the Treatment of Chronic Hepatitis B

September 6, 2023

Brii Biosciences Launches Amubarvimab/Romlusevimab Combination in China for the Treatment of COVID-19

Brii Biosciences Launches Amubarvimab/Romlusevimab Combination in China for the Treatment of COVID-19

July 7, 2022

PharmaShots Weekly Snapshot (October 21-25, 2019)

PharmaShots Weekly Snapshot (October 21-25, 2019)

October 29, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us